orfiril retard 300 mg
desitin arzneimittel gmbh - natriumvalproat - depottablett - 300 mg
valproat life medical 100 mg/ ml
life medical aps (1) - natriumvalproat - injeksjons-/infusjonsvæske, oppløsning - 100 mg/ ml
benzylpenicillin panpharma 1.2 g
panpharma sa - benzylpenicillinnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 1.2 g
benzylpenicillin panpharma 0.6 g
panpharma sa - benzylpenicillinnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 0.6 g
benzylpenicillin panpharma 3 g
panpharma sa - benzylpenicillinnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 3 g
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler for systemisk bruk, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.
alphagan 2 mg/ ml
abbvie as - brimonidintartrat - Øyedråper, oppløsning - 2 mg/ ml
monoprost 50 mikrog/ ml
laboratoires théa s.a.s - latanoprost - Øyedråper, oppløsning - 50 mikrog/ ml
taptiqom 15 mikrog/ ml / 5 mg/ ml
santen oy - tafluprost / timololmaleat - Øyedråper, oppløsning i endosebeholder - 15 mikrog/ ml / 5 mg/ ml
voltaren ophtha abak 1 mg/ ml
laboratoires théa - cedex 2 - diklofenaknatrium - Øyedråper, oppløsning - 1 mg/ ml